News: NOX Noxopharm Proposes To Evaluate Idronoxil Use In Patients, page-2

Those who watch the BBL will know that following a no-ball, a batsman has a free hit. They can't be dismissed - except if they run themselves out. Its a dream set of circumstances for a batsman to find themselves in. .

There is no downside, even if the batsman doesn't capitalize on the situation.

It might seem a strange comparison, but that is how I see it here. Its a win for Noxopharm and its a win for shareholders.We can't lose - there is no downside or drawback.

In a spooked market, buyers will surely be attracted, if only in the short term, to that kind of certainty.

The company may make a swing and miss. But if it hits a six, happy days.